Sitemap
September 08, 2019 Articles
Filter by Available Specialty
- Ipilimumab-nivolumab combination safe for historically unstudied patients with lung cancer
- Novel KRAS inhibitor induces disease control in 96% of treated patients with non-small cell lung cancer
- Read OSN's Sept. 10 publication exclusives online
- Researchers identify mutations associated with treatment sensitivity, resistance in NSCLC
- Survey shows low uptake of surgical antimicrobial prophylaxis guidelines
- Top 10 recent diet and nutrition news reports
- Top intervention news of August: TAVR low-risk indications, FDA paclitaxel advisory and more
- Trigger finger release in OR at one center associated with higher cost vs in the procedure room